IL6ST and breast cancer: The loss of IL6ST is involved in pathways related to lymphovascular invasion in breast cancer patients (17) and its function has been associated with other physiologies such as myocardial and hematological development where embryos of mice deficient for IL6ST gradually die between 12.5 days post-coitum (18).